MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with C

Calcium carbonate + Magnesium carbonate

Calcium carbonate 680mg / Magnesium carbonate heavy 80mg chewable tablets

No stability information

Stability notes for Calcium carbonate 680mg / Magnesium carbonate heavy 80mg chewable tablets

There are no stability notes for this medicine.

Suppliers

Rennie Peppermint chewable tablets (Bayer Plc)
Rennie Spearmint chewable tablets (Bayer Plc)

Calcium carbonate 680mg / Magnesium carbonate heavy 80mg chewable tablets sugar free

No stability information

Stability notes for Calcium carbonate 680mg / Magnesium carbonate heavy 80mg chewable tablets sugar free

There are no stability notes for this medicine.

Supplier

Rennie Sugar Free chewable tablets (Bayer Plc)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.